Literature DB >> 12574227

Cyclic changes in the expression of steroid receptor coactivators and corepressors in the normal human endometrium.

Tanri Shiozawa1, Hsien-Chang Shih, Tsutomu Miyamoto, Yu-Zhen Feng, Junko Uchikawa, Kazuko Itoh, Ikuo Konishi.   

Abstract

To examine the sex steroid-dependent growth mechanisms of the human endometrium, the expression of steroid receptor coactivators [steroid receptor coactivator-1 (SRC-1) and p300/CREB-binding protein (p300/CBP)] and corepressors (nuclear receptor corepressor and silencing mediator for retinoid and thyroid hormone receptors) was examined by immunohistochemistry, using 50 samples of normal endometria, and was compared with that of estrogen receptors (ER), progesterone receptors (PR), and proliferation marker Ki-67. In addition, actual binding of the coactivators to ER or PR was analyzed by immunoprecipitation. The expression of SRC-1 was diffusely observed in glandular and stromal cells in the proliferative phase and drastically decreased in the secretory phase. Such change in the expression pattern of SRC-1 resembled that of ER, PR, and Ki-67. On the other hand, p300/CBP expression was relatively constant throughout the menstrual cycle, with slight predominance in the proliferative phase. The expression of corepressors nuclear receptor corepressor and silencing mediator for retinoid and thyroid hormone receptors was focal in the endometrium. Immunoprecipitation, using tissue samples of both proliferative and secretory phases, revealed the complex formation between the coactivators and receptors. Binding of SRC-1 to ER was observed in the proliferative (but not in the secretory) endometrium. In contrast, binding p300/CBP to ER was noted in the endometria of both phases. Complex formation between p300/CBP and PR was noted in the secretory endometrium, whereas that between SRC-1 and PR was not apparent. Accordingly, we showed the expression pattern of steroid receptor coactivators and corepressors in the normal endometrium. Cyclic change in the expression of SRC-1 during the menstrual cycle might be important in the estrogen-action for the glandular and stromal cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12574227     DOI: 10.1210/jc.2002-020946

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  22 in total

Review 1.  Neuroactive steroids: A therapeutic approach to maintain peripheral nerve integrity during neurodegenerative events.

Authors:  Emanuela Leonelli; Marinella Ballabio; Antonio Consoli; Ilaria Roglio; Valerio Magnaghi; Roberto C Melcangi
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

2.  TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone.

Authors:  Florence Gizard; Romain Robillard; Barbara Gross; Olivier Barbier; Françoise Révillion; Jean-Philippe Peyrat; Gérard Torpier; Dean W Hum; Bart Staels
Journal:  Mol Cell Biol       Date:  2006-10       Impact factor: 4.272

Review 3.  Uterine disorders and pregnancy complications: insights from mouse models.

Authors:  Hyunjung Jade Lim; Haibin Wang
Journal:  J Clin Invest       Date:  2010-04-01       Impact factor: 14.808

4.  Nuclear receptor, coregulator signaling, and chromatin remodeling pathways suggest involvement of the epigenome in the steroid hormone response of endometrium and abnormalities in endometriosis.

Authors:  Z Zelenko; L Aghajanova; J C Irwin; Linda C Giudice
Journal:  Reprod Sci       Date:  2011-12-02       Impact factor: 3.060

5.  Cytokine and progesterone receptor interplay in the regulation of MUC1 gene expression.

Authors:  Neeraja Dharmaraj; Peng Wang; Daniel D Carson
Journal:  Mol Endocrinol       Date:  2010-10-20

6.  Immunohistochemical detection of steroid receptor cofactors in ovarian endometriosis: involvement of down-regulated SRC-1 expression in the limited growth activity of the endometriotic epithelium.

Authors:  Akihisa Suzuki; Akiko Horiuchi; Kenji Oka; Tsutomu Miyamoto; Hiroyasu Kashima; Tanri Shiozawa
Journal:  Virchows Arch       Date:  2010-02-13       Impact factor: 4.064

7.  Deregulation of estrogen receptor coactivator proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor in human endometrial tumors.

Authors:  Ratna K Vadlamudi; Seetharaman Balasenthil; Russell R Broaddus; Jan-Ake Gustafsson; Rakesh Kumar
Journal:  J Clin Endocrinol Metab       Date:  2004-12       Impact factor: 5.958

8.  SRC-1 is involved in the control of the gene expression of myelin protein Po.

Authors:  Ilaria Teresa Rita Cavarretta; Luciano Martini; Marcella Motta; Carolyn Louise Smith; Roberto Cosimo Melcangi
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

9.  Expression of transcription factors in endometrium during natural cycles.

Authors:  Vicente Maldonado; José Antonio Castilla; Luis Martínez; Alfonso Herruzo; Angel Concha; Juan Fontes; Nicolás Mendoza; María Luisa García-Peña; José Luis Mendoza; Rosa Magán; Agueda Ortiz; Esther González
Journal:  J Assist Reprod Genet       Date:  2003-11       Impact factor: 3.412

Review 10.  Progesterone action in human tissues: regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expression.

Authors:  Katherine M Scarpin; J Dinny Graham; Patricia A Mote; Christine L Clarke
Journal:  Nucl Recept Signal       Date:  2009-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.